Abstract
Immune checkpoint inhibitors (ICIs) are potentially life-saving cancer therapies that can trigger immune-related adverse events (irAEs). irAEs can imp......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
